TABLE 1

Baseline Characteristics

CharacteristicHCC, n = 99CCC, n = 13
Age (y)
 <5029 (29.3)1 (7.7)
 ≥5070 (70.7)12 (92.3)
Sex
 Male78 (78.8)10 (76.9)
 Female21 (21.2)3 (23.1)
Etiology*
 Hepatitis B79 (79.8)4 (30.8)
 Hepatitis C8 (8.1)2 (15.4)
 Alcohol8 (8.1)2 (15.4)
 Other5 (5.0)5 (38.4)
Child–Pugh class
 A89 (89.9)12 (92.3)
 B10 (10.1)1 (7.7)
EGOG performance
 065 (65.7)8 (61.5)
 127 (27.2)3 (23.1)
 27 (7.1)2 (15.4)
Tumor size (cm)
 ≥1, <27 (7.8)0 (0)
 ≥2, <542 (46.7)4 (30.8)
 ≥541 (45.5)9 (69.2)
Tumor number
 146 (51.1)5 (38.5)
 211 (12.2)0 (0)
 33 (3.3)0 (0)
 ≥430 (33.4)8 (61.5)
Tumor type
 Well defined78 (86.7)6 (46.2)
 Ill defined12 (13.3)7 (53.8)
Portal/hepatic vein invasion
 No63 (70.0)7 (53.8)
 Yes27 (30.0)6 (46.2)
Tumor differentiation
 I9 (9.8)
 II51 (55.4)
 III29 (31.6)
 IV3 (3.3)
α-fetoprotein (ng/mL)
 <2043 (43.4)
 20–40028 (28.3)
 >40028 (28.3)
Modified UICC stage
 I5 (5.1)0 (0)
 II37 (37.3)3 (23.1)
 III16 (16.2)3 (23.1)
 IVa13 (13.1)3 (23.1)
 IVb28 (28.3)4 (30.7)
BCLC stage
 Very early5 (5.1)
 Early16 (16.3)
 Intermediate35 (35.7)
 Advanced42 (42.9)
 Terminal1 (1.0)
  • * One patient had both hepatitis B virus and hepatitis C virus.

  • Among 99 HCC patients, 9 patients had only distant metastases without primary liver lesion after previous resection and 90 patients had primary HCC.

  • Edmonson–Steiner grade: 7 of 90 patients with primary HCC had inappropriate biopsy specimen for evaluation of pathologic grade, and 92 patients (83 primary HCC and 9 metastatic HCC) were finally evaluated.

  • ECOG = Eastern Cooperative Oncology Group.

  • Data in parentheses are percentages.